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Abstract 
Nosema ceranae is an obligate intracellular parasite and the etiologic agent of Nosemosis that affects honeybees. 
Beside the stress caused by this pathogen, honeybee colonies are exposed to pesticides under beekeeper interven‑
tion, such as acaricides to control Varroa mites. These compounds can accumulate at high concentrations in apicul‑
tural matrices. In this work, the effects of parasitosis/acaricide on genes involved in honeybee immunity and survival 
were evaluated. Nurse bees were infected with N. ceranae and/or were chronically treated with sublethal doses of 
coumaphos or tau‑fluvalinate, the two most abundant pesticides recorded in productive hives. Our results demon‑
strate the following: (1) honeybee survival was not affected by any of the treatments; (2) parasite development was 
not altered by acaricide treatments; (3) coumaphos exposure decreased lysozyme expression; (4) N. ceranae reduced 
levels of vitellogenin transcripts independently of the presence of acaricides. However, combined effects among 
stressors on imagoes were not recorded. Sublethal doses of acaricides and their interaction with other ubiquitous 
parasites in colonies, extending the experimental time, are of particular interest in further research work.
© 2016 Garrido et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Pesticide exposure and pathogen infection are recognised 
as potential stressors affecting honeybee populations and 
consequently the profitability of beekeeping, such as par-
asitic mite syndrome or varroosis [1, 2], several viruses 
[3, 4], xenobiotics [5, 6] and microsporidiosis [7].
Nosema ceranae [8–10] is the predominant microspo-
ridian pathogen, originally isolated from Apis cerana [11] 
but recently it has been reported as a natural parasite of 
A. mellifera over the world [12]. This obligate intracellu-
lar microparasite spreads among hosts via spores and is 
the etiologic agent of Nosemosis.
With respect to chemical stressors, honeybee colonies 
are exposed to pesticides used in agriculture or within 
bee hives by beekeeper intervention. In order to con-
trol Varroa destructor, the causative agent of varroosis, 
beekeepers apply synthetic acaricides, with the most 
commonly employed being the neurotoxic compounds 
coumaphos (organophosphate) and tau-fluvalinate (pyre-
throid) (reviewed in [13]). These acaricides are applied 
directly to bee hives and accumulate in apicultural matri-
ces, particularly beeswax [14], being detected in nearly all 
hives tested in several countries [15–19].
It has been suggested that tau-fluvalinate increases 
honeybee susceptibility to deformed wing virus infec-
tion [20], and that coumaphos can act as a systemic 
agent inside the colonies [21] and alters some metabolic 
responses [22]. Nevertheless, these molecules did not 
alter immunity at the gene expression level in bees sub-
ject to acute exposure in laboratory conditions [23].
Insects lack an acquired immune system but have 
a well-developed innate response [24]. In honeybees, 
humoral immunity involves antimicrobial peptide (AMP) 
synthesis [25]. Four AMP, abaecin, apidaecin, defensin 
and hymenoptaecin have been identified in A. mellif-
era when honeybees are challenged by bacteria [26, 27]. 
On the contrary, cellular defence involves phagocytosis, 
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encapsulation and nodulation mediated mostly by hemo-
cytes [28]. These latter processes are related to melanisa-
tion, a mechanism catalysed by phenoloxidase [29] and 
glucose dehydrogenase (GLD) [30]. Another component 
of worker bee defence is vitellogenin, synthesized by 
the fat body and released into the hemolymph [31, 32]. 
This yolk protein is involved in many physiological pro-
cesses, for example in the regulation of honeybee longev-
ity, immunity, brood food synthesis or acting as a stress 
response mediator [33]. Antúnez et al. [34] showed evi-
dence that honeybee colonies with different degrees of 
N. ceranae infection could be associated to a differential 
expression of vitellogenin.
Currently, the requirement of high doses of acaricides 
due to V. destructor resistance added to the potential of 
honeybee colonies to accumulate acaricide residues and 
their metabolites has become detrimental to honeybee 
health and productivity. For this reason, the evaluation of 
sublethal effects of acaricides is essential to gain informa-
tion on the long term effects of these widely used com-
pounds in beekeeping.
The objective of this study was to determine whether 
exposure of adult bees to chronic sublethal acaricide 
(tau-fluvalinate and coumaphos) and/or infection with 
N. ceranae generates significant effects on individual 
immune components and honeybee survival.
Materials and methods
Colony health conditions and preparation of acaricide‑free 
combs
Local hybrid honeybees (A. mellifera mellifera/A. mel-
lifera ligustica) were obtained from colonies located 
in the experimental apiary J. J. Nágera coastal station 
(38°10′06″S, 57°38′10″W), Mar del Plata, Argentina.
Mite infestation levels in the apiary were monitored 
using the natural mite fall method [13]. Also, phoretic 
Varroa mite infestation rates were determined according 
to Fries et al. [35].
In order to evaluate the presence of Nosema spp. 
spores in the apiary, 60 forager honeybees returning 
from flight from each colony were macerated and exam-
ined using light microscopy [36]. Three colonies were 
selected to obtain brood combs based on the lowest 
prevalence recorded from Varroa mites (less than 1%) 
and the lowest abundance from N. ceranae (an average of 
5 ×  105 Nosema spores/bee). Specifically, neither of the 
colonies used to obtain the imagoes presented any visible 
clinical symptoms of other diseases (i.e., American foul-
brood or chalkbrood).
No chemical treatment was applied to the colonies 
5 months before and during the experiment.
Four months prior to the beginning of the assays, in 
order to avoid the presence of long lasting acaricide 
residues in wax or honey [14], a plastic foundation was 
used allowing bees to draw out the foundation since new 
commercial beeswax foundation are paradoxically con-
taminated with residuals [37]. Plastic foundations were 
covered with a thin layer of virgin wax to get a better 
acceptance of these supports. Then they were placed in 
the selected colonies.
Nosema ceranae spores
Foraging bees were collected from a naturally infected 
colony of the experimental apiary mentioned above. 
The spore number was determined using a hemocytom-
eter under light microscopy. The presence of N. ceranae 
spores and the absence of N. apis spores was confirmed 
by PCR [38].
In order to avoid microbial contaminants and host tis-
sue, fresh spore suspensions were purified following a 
triangulation method modified by Fries et  al. [39]. The 
obtained suspension was immediately used for experi-
mental infection.
Chemicals
Technical grade chemicals were used for all trials. The 
acaricides coumaphos and tau-fluvalinate were obtained 
from Sigma-Aldrich®.
Experimental infection with N. ceranae spores
Newly emerged bees, which are free from N. ceranae 
infection [9, 40], from three colonies were mixed together 
and were placed in wooden cages with a plastic mesh 
(11 × 9 × 6 cm3) in groups of 150. They were also provi-
sioned with bee bread (stored at −20 °C for 3 months in 
order to eliminate viable spores) manually collected from 
plastic combs from honeybee colonies, water and sucrose 
syrup ad libitum.
Individual infection was achieved on day 3 after emer-
gence according to Porrini et  al. [41]. Honeybees were 
starved 5 h and then more than 600 individuals received 
10 μL of sucrose–water solution (2:1 w:v) with 1.5 × 105 
Nosema spores. The solution was continuously vor-
texed to ensure a uniform suspension. Approximately 
650 control honeybees were treated in the same man-
ner using sucrose-water solution (2:1 w:v) containing no 
Nosema spores. Those individuals that did not consume 
the total amount of solution were discarded from the 
assay. Then, they were caged in transparent and ven-
tilated plastic flasks of 900  cm3, these hoarding cages 
have inputs for feeding devices and removable sides. 
Four replicates of 50 imagoes per treatment were made 
and maintained in an incubator (28 °C; 30% HR). Hon-
eybees were fed ad  libitum with bee bread, water and 
sucrose syrup. A chronology of the experiment is shown 
in Table 1.
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Selection of sublethal dose of acaricides
The experiment was designed in order to simulate real-
istic conditions of exposure to acaricides. Concentra-
tions were based on previous data on the presence of 
these pesticides in pollen and honey. In the case of tau-
fluvalinate, a concentration of 750  ppb was detected 
in honey [42] and 487.2 ppb in pollen [43], the selected 
dose was approximately the average between those val-
ues (666 ppb). In the case of coumaphos, 2020 ppb were 
found in honey samples [17] and 5800  ppb in pollen 
[18], so the selected dose was approximately the average 
(3333 ppb).
Chronic exposure bioassays
Four-day-old worker bees were used for all bioassays 
(Table 1). Acaricidal compounds were dissolved in etha-
nol 96%. The final concentration of ethanol in sugar syrup 
was 2%; at this percentage it has been demonstrated that 
behaviour components are not affected in acute expo-
sures [44]. Additionally, control bees received the same 
concentration of ethanol. Honeybees were treated per os 
with solutions of coumaphos (3333  ppb) or tau-fluvali-
nate (666 ppb) added to sugar syrup. Bees were supplied 
with one of the following diets: sucrose syrup + tau-flu-
valinate, sucrose syrup  +  coumaphos or control syrup. 
Also frozen bee bread and water were administered 
ad  libitum and honeybees were maintained in an incu-
bator (28  °C; 30% HR) for 9  days under the treatments 
mentioned above. Solutions were administered in gravity 
feeders and were replaced daily, recording consumption 
every day through differences in feeder weight. Solution 
evaporation was checked in order to correct the con-
sumed volumes.
In summary, honeybees were treated as follows: non-
infected without acaricide exposure (C), non-infected 
exposed to tau-fluvalinate (CFluv), non-infected exposed 
to coumaphos (CCou), Infected without acaricide expo-
sure (I), infected exposed to tau-fluvalinate (I  +  Fluv), 
infected exposed to coumaphos (I + Cou).
Nosema ceranae development
Ten days post-infection, fifteen to thirty bees per repli-
cate were analysed in order to individually quantify the 
parasite development. The digestive tract was removed 
by pinching the last abdominal segments and cutting the 
midgut. Midguts were stored at −20 °C until quantifica-
tion. The number of spores in suspension (parasite inten-
sity) was individually quantified with a hemocytometer 
under a light microscope [45].
Bee sample preparation for molecular analysis
For total RNA extraction, ten bees belonging to each 
experimental group were collected at day 13 after emer-
gence, sliced in pieces and individually merged in 1 mL of 
RNA later® (Ambion, Inc. Austin, TX, USA) in order to 
avoid the degradation of mRNA.
RNA isolation and cDNA synthesis
Ten bees per group (3 or 4 individuals per replicate) were 
individually analysed. RNA later was partially removed 
from samples. Honeybees were homogenised using a ster-
ile glass rod and a sterile plastic tube. An aliquot of the 
body homogenates obtained to evaluate gene expression 
was also analysed to determine the presence of Nosema 
spores under light microscopy. Then, 600 µL of RLT buffer 
(Qiagen) were added to homogenates. Total RNA was iso-
lated using the RNeasy plus mini kit (Qiagen), according 
to the manufacturer’s instructions. Total RNA recovered 
was immediately used to generate first strand cDNA using 
the quanti tect reverse transcription kit (Qiagen), accord-
ing to the manufacturer’s instructions. Resultant cDNA 
synthesized were stored at −20 °C.
Negative controls were added in parallel for each step 
(RNA extraction and reverse transcription reactions).
Gene and primer selection
In order to evaluate the effect of acaricides on immune-
related genes of honeybees, transcript levels for the genes 
encoding the antimicrobial peptides abaecin (ABA), 
hymenoptaecin (HYM), defensin (DEF), the immune 
related proteins, glucose dehydrogenase (GLD), lysozyme 
(LYS), vitellogenin (VG) were assessed using primers 
previously described [25, 46, 47]. Gene transcripts were 
normalized relative to expression levels for the gene 
encoding ribosomal protein S5 (RPS5), a gene with con-
stitutive expression across honeybee life stages [48] and 
disease status and β-actin, a moderately expressed house-
keeping gene [47].
Table 1 Chronological description of experimental procedure
1 day‑old individuals 3 day‑old 4 day‑old 13 day‑old
Cage rearing
Diet: bee bread, sucrose solution 
(66%) and water ad libitum
Individual inoculation with or 
without N. ceranae spores in 
sucrose solution
Beginning of the administration 
of acaricide or sucrose only 
solution for controls
Daily replacement of solutions 
until day 13 post emergence
Sampling bees for individual quantification of 
spores in midgut and individual gene expres‑
sion analysis
Page 4 of 9Garrido et al. Vet Res  (2016) 47:51 
Primers used for quantitative PCR of honeybee tran-
scripts are summarized in Additional file 1.
Real‑time PCR
Real-time PCR reactions for the amplification of specific 
genes were performed in 96-well plates using a BIO-
Rad CFX-96 thermal cycler (Bio-Rad Corp.). Reaction 
mixtures consisted of 1×  QuantiTect SYBR Green PCR 
Master Mix, 0.5 µM of each primer (one pair of primers 
per reaction), RNAse free water and 5 µL of 1:10 diluted 
cDNA in a final volume of 25 µL.
PCR reactions were conducted using a thermal pro-
gram consisting of an initial activation step at 50  °C for 
2  min and 95  °C for 15  min, and 39 cycles of 94  °C for 
15 s, 50 °C for 30 s and 72 °C for 30 s. Fluorescence was 
measured in the elongation step. Negative controls lack-
ing template were run by excluding nucleic acids from 
reactions.
Specificity of the reaction was checked by analysis of 
the melting curve of the final amplified product (from 65 
to 95 °C).
Normalization of the real‑time data
Amplification results from different genes were expressed 
as the quantification cycle (Cq) value. According to a sug-
gestion made by Vandesompele et  al. [49], the geomet-
ric mean between the Cq of two reference genes (RPS5 
and β-actin) was used for analysis. The expression ratio 
between each target gene and the geometric mean of 
reference genes was calculated according to the method 
described by Pfaffl [50].
Statistical analyses
Prior to analysis, graphical explanatory techniques were 
applied to the original data to identify outliers and col-
linearity [51, 52].
Abundance of parasites
The abundance of parasites observed for each honeybee 
specimen was initially modelled using a generalized lin-
ear mixed model (GLMM) with a Poisson distribution 
and log link function. Nevertheless, due to more vari-
ability (overdispersion) than expected under the assumed 
distribution, a negative binomial distribution was pre-
ferred, resulting in the following model:
The random intercept ai introduces a correlation struc-
ture between all observations from the same sampling 
cage [53, 54].
Parasitesij ∼ NB (µij, k); Log (µij) = Intercept+
factor (Treatment)ij + ai, where ai ∼ N
(
0, σ 2cage
)
.
Survival analysis
A similar model was also performed using a GLMM with 
a binomial distribution. The response variable Yi is the 
number of bees that survived after treatment, of Ni bees 
treated for a period of 13 consecutive days. To model this 
probability, we used the logistic link function of the form:
The term ai is a random intercept for cagei and imposes 
a correlation on all observations from the same cage.
Consumption rates
The relationship between average food consumption 
(milligrams/hour/bee) versus day, treatment identity and 
their interaction, was defined using a linear mixed model 
(LME) [53, 55, 56]. As mentioned above, the term ai is the 
random effect and is assumed to be normally distributed 
with mean 0 and variances σ2. The term εij is the unex-
plained noise, and is assumed to be normally distributed 
with mean 0 and σ2.
The following model was applied:
Gene expression
Linear mixed effects models (LME) were used to model 
the gene expression as a response, in relation to the 
explanatory variable treatment. For each treatment 
level, gene expression was sampled from the same speci-
men. Hence, it is likely that individual gene expression is 
dependent on one another. Therefore to avoid a certain 
degree of pseudo-replication when fitting six separate 
models, an N by N correlation matrix was calculated 
a posteriori. The off-diagonal elements define the cor-
relation between the residuals of each gene expres-
sion analysis and was used to assess dependency among 
the response variables. Thus, the following model was 
applied on the data obtained for each gene expression:
The term ai is the random effect representing the 
between-cage variation and is assumed to be normally 
distributed with mean 0 and variances σ2. The term εij is 
the unexplained noise, and is assumed to be normally dis-
tributed with mean 0 and σ2. However, an initial analysis 
indicated large variation due to the effect of the covariate 
treatment, and therefore we allowed for heterogeneous 
residual variance structures [53, 55, 56].
logit
(
piij
)
= Intercept + factor (Treatment)ij + Daysij + ai,
where ai ∼ N
(
0, σ 2cage
)
.
Food consumptionij = Intercept
+ factor (Treatment)ij ∗ Dayij + ai + εij.
Gene expressionij = Intercept + factor (Treatment)ij
+ ai + εij.
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The model selection followed the step-down approach 
described in West et al. [56] and Zuur et al. [53]. Signifi-
cance of the variable treatment within the models was 
assessed using p values, which explains the effect of indi-
vidual level of factor on the response variable as com-
pared to the controls.
A detailed model validation was carried out by plotting 
residuals versus fitted values and versus each covariate to 
confirm that the underlying statistical assumptions were 
not violated [53, 54]. For the LME models, optimal model 
coefficients were derived using REML estimation [53, 
56]. All analyses were performed with R (R Development 
Core Team, 2014) using the packages lme4 and nlme, 
respectively [57, 58].
Results
Nosema ceranae infection on honeybees
Sublethal doses of coumaphos and tau-fluvalinate did not 
alter N. ceranae development. Statistical analysis revealed 
no significant differences between experimental groups 
(X2 = 1.48, df = 2, p = 0.47).
The recorded mean of spores  ±  standard errors per 
bee in infected controls was 11  534  261  ±  1 236  776; 
12  104  406  ±  1  081  263 for coumaphos treated bees 
and 11  923  054 ±  1  114  173 for tau-fluvalinate treated 
ones. Less than 8% of artificial infected honeybees did 
not have spores in their midgut when analysed by light 
microscopy.
No N. ceranae spores were recorded in non-infected 
honeybees, demonstrating that no spore contamination 
in the bee bread diet and the absence of unwanted infec-
tion of bees occurred during the assays.
Honeybee survival
Model selection indicated that there was no significant 
effect of treatment identity on survival rates (X2 = 3.29, 
df  =  5, p  =  0.65) indicating that administrated cou-
maphos and tau-fluvalinate did not alter mortality 
of infected or non-infected honeybees. However, the 
probability of survival declined significantly after the 
start of the experiment (X2 = 534.14, df = 1, p < 0.001) 
(Figure 1).
Food intake
The optimal model for food consumption was an LME, 
where food consumption was mainly affected by treat-
ment variable (L-ratio  =  22.23, df  =  5, p  <  0.001). 
There was no significant interaction between the days 
of consumption and treatments (L-ratio =  4.13, df =  5, 
p = 0.53). The effect of time (days) was neither significant 
(L-ratio = 0.86, df = 1, p = 0.37).
Significant differences were only detected on infected 
honeybees that received coumaphos treatment when 
compared to controls (p  =  0.007). Figure  2 shows the 
results of LME for food consumption.
Immune‑related gene expression
Expression levels of genes involved in immune response 
were determined 10  days after infection (13  days after 
emergence). Gene-specific amplification was confirmed 
for the six genes analysed, as a single peak in the melt-
ing curve analysis and through the Tm values. No ampli-
fication occurred for negative controls (non-template 
controls).
Nosema ceranae spore presence was confirmed, under 
a light microscope, before total RNA extraction in all 
infected honeybee samples. In contrast, no spores were 
detected in non-infected honeybees.
Two of the six statistical models did not fulfil the 
assumptions of the LME and therefore we failed to vali-
date them. This was mainly due to the presence of neg-
ative fitted values and/or heterogeneity of variances. 
Therefore no results are presented for hymenoptaecin 
and glucose-dehydrogenase gene expressions. With 
respect to the defensin gene expression, the data set con-
tained a considerable number of missing values for a level 
of the factor treatment, therefore we could not include 
the “non-infected exposed to coumaphos” level in the 
analysis.
Figure 1 Honey bee survival. Predicted survival values according 
to each treatment and days after inoculation. Treatments: C (control); 
I (infected honeybees); CFluv (non‑infected honeybees fed with 
666 ppb of tau‑fluvalinate); I + Fluv (infected honeybees fed with 
666 ppb of tau‑fluvalinate); CCou (non‑infected honeybees fed with 
3333 ppb of coumaphos); I + Cou (infected honeybees fed with 
3333 ppb of coumaphos).
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Genes that encode for antimicrobial peptides
Treatments did not show a significant effect on abaecin 
(L-ratio = 9.48, df = 5, p = 0.09) nor defensin transcript 
levels (L-ratio = 0.85, df = 5, p = 0.97).
Genes that encode lysozyme and vitellogenin
The optimal model describing vitellogenin mRNA levels 
was an LME that allowed for unequal variances depend-
ing on infection vs non-infection. The “non-infected 
exposed to coumaphos” treatment was removed from 
the statistical analysis due to a considerable number 
of missing values that were not accepted by the model. 
Vitellogenin gene expression was affected by treatments 
(L-ratio = 12.27, df = 4, p = 0.01). This is a significant, 
albeit weak effect (Figure 3).
Nosema ceranae infection caused a reduction in tran-
script abundances of vitellogenin (VG) when compared to 
the control treatment (p = 0.01). Also, when both stress-
ors were applied a drop of VG was detected (p = 0.02).
The tau-fluvalinate treatment did not cause a reduction 
by itself in VG gene expression; however the combination 
of this acaricide and N. ceranae infection did (p = 0.04) 
(Figure 3).
In the case of lysozyme expression analysis, the opti-
mal model was also an LME with unequal variances. 
The results revealed that lysozyme transcript levels 
were primarily affected by treatment (L-ratio  =  20.92, 
df = 5, p < 0.001). When comparing the treatment levels 
with the control, we found that non-infected honeybees 
exposed to coumaphos expressed significantly lower rela-
tive abundances of transcript compared to the baseline 
(t = −3.09; p  <  0.01), and that non-infected honeybees 
that received tau-fluvalinate treatment also had a nega-
tive but weak influence on gene expression (t = −2.09; 
p = 0.05) (Figure 4).
Discussion
In spite of the ubiquitous presence of N. ceranae and 
highly persistent acaricides in apicultural matrices, 
our results revealed under carefully controlled labora-
tory conditions, no evidence of combined effects of 
those stressors on honeybee survival and in most of the 
immune related genes analysed.
It is worth noting that coumaphos and tau-fluvalinate 
concentrations provided in our study have been reported 
Figure 2 LME results for food consumption. Sucrose consump‑
tion is expressed as the amount of sucrose solution (50% w/v, ad libi‑
tum delivery) consumed daily, per hour and per bee during the assay 
(food intake). The black dots represent the fitted values, and the lines 
are 95% confident intervals. Raw data were superimposed (grey dots). 
Treatments: C (control); I (infected honeybees); CFluv (non‑infected 
honeybees fed with 666 ppb of tau‑fluvalinate); I + Fluv (infected 
honeybees fed with 666 ppb of tau‑fluvalinate); CCou (non‑infected 
honeybees fed with 3333 ppb of coumaphos); I + Cou (infected 
honeybees fed with 3333 ppb of coumaphos). Asterisk indicates 
significant differences (df: 207; p = 0.0078) with control treatment (C).
Figure 3 Vitellogenin mRNA expression. LME results. The black 
dots represent the fitted values, and the lines are 95% confidence 
intervals. Raw data were superimposed (grey dots). Gene expression 
was primarily affected by treatment (L‑ratio = 12.27, df = 4, p = 0.01). 
Treatments: C (control); I (infected honeybees); CFluv (non‑infected 
honeybees fed with 666 ppb of tau‑fluvalinate); I + Fluv (infected 
honeybees fed with 666 ppb of tau‑fluvalinate); I + Cou (infected 
honeybees fed with 3333 ppb of coumaphos). Treatments I, I + Fluv 
and I + Cou were significantly lower than control treatment 
(t = −2.62, t = −2.13 and t = −2.47 respectively; p = 0.01, p = 0.04 
and p = 0.02 respectively). Asterisk indicates statistically significant 
differences with treatment (C).
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in contaminated honey and pollen stored inside hives 
[17, 18, 45, 46], therefore acaricide-honeybee interactions 
are likely to occur under field-realistic scenarios. Chronic 
administration of these acaricides during 9 days did not 
affect worker survival, nor in coexposure with N. ceranae 
under laboratory conditions. Our test bees only received 
acaricide exposure as imagoes, and larvae developed in a 
reduced acaricide environment, therefore it will be inter-
esting to analyse exposure to sublethal levels on survival 
even during larval development.
It is unsurprising that insecticides alter insect behav-
iour, such as feeding levels but, in this work, intake of 
diets was similar to control group. In other words, the 
observed responses were not due to poor nutrition. Only 
infected bees that received syrup contaminated with cou-
maphos showed a reduced consume when compared to 
controls. This result might be clarified by performing 
long lasting assays.
Although colonies employed during the assays did not 
show any clinical symptom of diseases, pathogens could 
be present in the administered inoculum or in the pollen 
diet. However, until this work was conceived, no pub-
lished method have been proposed in order to avoid the 
possible presence of pathogens without altering the high-
est nutritional quality of beebread. This should be consid-
ered in future experimental designs.
Recently, an increase in Nosema spore loads in colo-
nies treated with the insecticide imidacloprid was shown, 
suggesting an indirect effect of pesticides on pathogen 
growth in honeybees [59]. In our study, Nosema growth 
rate did not change in the presence of coumaphos or tau-
fluvalinate at sublethal doses, in agreement with recent 
field work in naturally infected colonies [60].
Nosema ceranae infection by itself did not have an 
effect on genes that encode antimicrobial peptides nor 
tested enzymes at day 10 post infection. Only a signifi-
cant downregulation of vitellogenin was detected in N. 
ceranae infected honeybees. These results agreed with 
those found by Antúnez et al. [61] who showed that vitel-
logenin transcripts decreased in N. ceranae infected bees 
at 7 days post infection. However, Chaimanee et al. [62] 
did not find differences in vitellogenin expression levels 
at day 13 post emergence but methodologies were dis-
similar, mainly since they did not provide any protein 
source. In reference to the importance of the diet, a posi-
tive correlation between the level of pollen consumption 
and Vg expression in Nosema-infected bees has been 
widely demonstrated, underlining the importance of the 
diet [63].
Although a reduction in Vg transcripts was recorded in 
infected honeybees treated with tau-fluvalinate and cou-
maphos, this was due to the parasite action. The vitello-
genin protein is a central regulator of lifespan, supporting 
hemocyte viability [32], recognizing cell damage [64] and 
acting as a metabolic regulator of stress responses [33]; 
altering its expression rates induced by the presence of N. 
ceranae, independently of acaricide exposure, could lead 
to an acceleration on honeybee ontogeny [33] and reduc-
tion of its antioxidant capacity. The limited knowledge 
of the impact of chemical pesticides on humoral immu-
nity postulates that they do not appear to affect AMP 
production [65]. This agrees with our study, since no 
differences in defensin or abaecin transcript levels were 
found on bees exposed to tau-fluvalinate or coumaphos 
treatments.
In the present study, effects on the lysozyme gene on 
honeybees at sublethal chronic exposure were recorded 
but in a previous report, no change was observed under 
acute exposure (LC50) employing the same acaricides 
[23]. Although it should be considered that differ-
ent methodologies related to acaricide exposure were 
employed, such as the evaluation of acute toxicity by 
contact, we can hypothesize that huge amounts of these 
molecules administrated over 24  h do not impact on 
Figure 4 Lysozyme mRNA expression. Results of the LME. 
The black dots represent the fitted values, and the lines are 95% 
confidence intervals. Raw data were superimposed (grey dots). Gene 
expression was primarily affected by treatment (L‑ratio = 20.92, 
df = 5, p < 0.001). Treatments: C (control); I (infected honeybees); 
CFluv (non‑infected honeybees fed with 666 ppb of tau‑fluvalinate); 
I + Fluv (infected honeybees fed with 666 ppb of tau‑fluvalinate); 
CCou (non‑infected honeybees fed with 3333 ppb of coumaphos); 
I + Cou (infected honeybees fed with 3333 ppb of coumaphos). 
When compared with control, treatment CCou was significantly lower 
(t = −3.09; p < 0.01) and treatment CFluv also had a negative but 
weak influence on the gene expression (t = −2.09; p = 0.05). The 
asterisk indicates statistically significant differences with respect to 
control treatment (C).
Page 8 of 9Garrido et al. Vet Res  (2016) 47:51 
the immune system as much as little doses over a longer 
period of time; it seems that chronic stress can lead to a 
dysregulation of the physiological pathways to compen-
sate for the stress response.
The common feature of lysozymes in animals is their 
ability to hydrolyse bacterial cell wall [66] and to pro-
mote the synthesis of other antimicrobial peptides [67]. 
Chronic exposure to coumaphos reduced lysozyme tran-
scripts but in exposed honeybees infected with N. cera-
nae no differences were observed with respect to control 
treatments. This result may be due to the absence of 
response by individual honeybees in the presence of both 
stressors or that the parasite induces an up-regulation of 
this gene while the acaricide downregulates it, buffering 
the net effect. The energetic cost could be the key rea-
son behind this result because this parasite generates an 
energetic demand on its host. This could affect the mech-
anisms that regulate the mobilisation of energy reserves 
in infected individuals [68, 69].
The long term effects of tau-fluvalinate and coumaphos 
and their interaction with other ubiquitous parasites are 
of particular concern. Thus, the possible detrimental 
effects of these stressors on colony health and perfor-
mance cannot be discarded and warrant further research. 
Our interest in future studies will be to intensify sampling 
in order to reduce variability between individuals and to 
perform again those treatments or response variables that 
were necessary to exclude from statistical analyses. Also, 
since honeybee physiology is characterized by a surprising 
plasticity and is regulated by colony signals and resources, 
further field or semi-field studies are necessary.
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